Why is Welcure Drugs falling/rising?

As of 24-Jul, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 10.09, which reflects a decrease of 0.13 or 1.27%. The stock has underperformed its sector by 1.62% today, and its delivery volume has significantly dropped by 46.01% compared to the 5-day average, indicating falling investor participation. Despite a strong performance over the past year, with a return of 44.35%, the stock has faced substantial declines in the short term, with a 1-week return of -13.32% and a 1-month return of -33.18%. The stock is currently trading above its 200-day moving average but below its shorter-term moving averages, suggesting mixed signals regarding its price momentum.
In the broader market context, the Sensex has shown minimal movement with a 1-week return of -0.09% and a 1-month return of +0.16%, indicating that the stock's recent struggles are not reflective of the overall market trend. While Welcure Drugs has demonstrated impressive long-term growth, including a staggering 940.21% increase over the past five years, the recent price decline may be attributed to a combination of reduced trading activity and investor sentiment. The company has reported positive financial metrics, such as a significant increase in net sales and profits, which could suggest that the current price drop may be temporary, and the stock remains a hold for investors looking for potential recovery in the future.